Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13705-13717
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Figure 8 Quantification of ribonuclease protection assay of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-1, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-2, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4, GLUT1, hypoxia inducible factor-1α, and splice variants of VEGF-A mRNA in human gastric malignant tumors (T) and corresponding non-malignant tissue (N) from the same patients.
bP < 0.01 vs control cells[32]. HIF: Hypoxia inducible factor; PFKFB: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase; VEGF: Vascular endothelial growth factor.
- Citation: Minchenko OH, Tsuchihara K, Minchenko DO, Bikfalvi A, Esumi H. Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells. World J Gastroenterol 2014; 20(38): 13705-13717
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13705